J2 Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$988K Sell
824
-15
-2% -$15.3K 0.66% 21
2026
Q1
$772K Buy
839
+142
+20% +$144K 0.53% 34
2025
Q4
$749K Sell
697
-24
-3% -$22.9K 0.55% 30
2025
Q3
$550K Sell
721
-1
-0.1% -$744 0.41% 66
2025
Q2
$563K Buy
722
+253
+54% +$197K 0.45% 54
2025
Q1
$387K Buy
469
+7
+2% +$5.83K 0.36% 58
2024
Q4
$357K Buy
+462
New +$383K 0.33% 73
2023
Q3
$368K Buy
686
+25
+4% +$12.9K 0.47% 60
2023
Q2
$310K Sell
661
-88
-12% -$36.9K 0.37% 78
2023
Q1
$257K Buy
749
+32
+4% +$10.8K 0.4% 74
2022
Q4
$262K Sell
717
-449
-39% -$159K 0.45% 66
2022
Q3
$377K Sell
1,166
-10
-0.9% -$3.17K 0.72% 29
2022
Q2
$381K Sell
1,176
-221
-16% -$66.3K 0.58% 34
2022
Q1
$400K Buy
1,397
+25
+2% +$6.43K 0.44% 39
2021
Q4
$379K Buy
+1,372
New +$348K 0.36% 45

Other funds holding LLY

J2 Capital Management's LLY Position: Q2 2026 in Review

J2 Capital Management reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $15.3K and leaving 824 shares worth $988K. The position accounts for 0.66% of the portfolio, ranked #21.

J2 Capital Management first reported a position in LLY in Q4 2021 and has held it in 15 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • J2 Capital Management held 824 shares of Eli Lilly worth $988K as of Q2 2026.
  • J2 Capital Management sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.66% of J2 Capital Management's portfolio in Q2 2026, its #21 holding.
  • J2 Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 15 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on J2 Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.